MedPath
HSA Approval

LAMOTRIX TABLET 50 MG

SIN14027P

LAMOTRIX TABLET 50 MG

LAMOTRIX TABLET 50 MG

October 10, 2011

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N03AX09

lamotrigine

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE Ltd. (Central Factory)

MEDOCHEMIE (FAR EAST) LTD. (ORAL FACILITY)

Active Ingredients

LAMOTRIGINE

50.0 mg

Lamotrigine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LAMOTRIX TABLET 50 MG - HSA Approval | MedPath